Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-99
SponsorClaris Biotherapeutics, Inc.

About this trial

The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

A photopic BCVA in the prospective study eye(s) of ≤ 70 letters at the Screening and Day 1 visits AND a change of ≤ 10 letters in photopic BCVA at Day 1 compared to the Screening Visit

Qualifying LSCD diagnosis in the study eye(s) prior to enrollment at Day 1

Written confirmation that exclusions on retinal findings are met in the study eye(s) prior to enrollment at Day 1

Inflammation associated with LSCD or other non-infectious inflammation (e.g., dry eye, ocular rosacea, and blepharitis) that will not interfere with the subject's participation in the opinion of the investigator is permitted.

Disqualifiers

Any active ocular infection in either eye at either the Screening or Day 1 visits

Active sterile iritis or uveitis in either eye at Screening or Day 1 visits

Screening visit retinal exam finding, in the opinion of the investigator, that would limit potential for visual acuity gain in the study eye(s)

Trial population

Adult and adolescent subjects with qualifying LSCD

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Non-interventional

    Other intervention

    Non-interventional

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: Non-interventional1 intervention

Trial outcomes

Primary outcomes

1

Natural Progression of LSCD as Assessed by Changes in Patient Reported Outcomes

Onset or changes (worsening or improving) in vision-related quality of life and ocular symptoms as captured with the National Eye Institute Visual Function Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI) questionnaires

Time frame
Screening through Week 84
2

Natural Progression of LSCD as Assessed by Functional Changes (Photophobic BCVA)

Change in photophobic BCVA

Time frame
Screening through Week 84
3

Natural Progression of LSCD as Assessed by Functional Changes (Low-luminance BCVA)

Change in low-luminance BCVA

Time frame
Screening through Week 84
4

Natural Progression of LSCD as Assessed by Functional Changes (Low-contrast BCVA)

Change in low-contrast BCVA

Time frame
Screening through Week 84

Secondary outcomes

1

Changes that May be Correlated with LSCD as Assessed by Functional Changes (Corneal Sensitivity)

Changes (onset, improvement, or worsening) in corneal sensitivity

Time frame
Screening through Week 84
2

Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Corneal Topography/Tomography)

Changes (onset, improvement, or worsening) in corneal topography and/or tomography and/or densitometry

Time frame
Screening through Week 84
3

Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial Defect Frequency)

Changes (onset, improvement, or worsening) in epithelial defect frequency

Time frame
Screening through Week 84
4

Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Palisades of Vogt Crypts)

Changes (onset, improvement, or worsening) in Palisades of Vogt crypts

Time frame
Screening through Week 84

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.